Apellis Pharmaceuticals Inc.

05/02/2022 | Press release | Distributed by Public on 05/02/2022 13:40

Efficacy of intravitreal pegcetacoplan in patients with geographic atrophy (GA): 18-month results from the phase 3 OAKS and DERBY studies